Table 1.
Continued
Sensitivity† | Specimens | Comparisons | Reference |
---|---|---|---|
10 GE | 49 | Nested and real-time assays had equivalent sensitivity for 18 specimens | Drosten et al., 200312 |
100 GE | 19 patients | PCR more sensitive than culture | Ksiazek et al., 200313 |
NP | 10 patients | 5 of 6 patients were PCR-positive | Poutenen et al., 200310 |
10 GE | 68 | CBH nested and nonnested TaqMan RT-PCR Artus assay | Mahony et al., 200415 |
NP | 116 | No | Wang et al., 200418 |
1 to 10 GE | 44 | No-Detects other CoV as well as SARS-CoV | Adachi et al., 200421 |
NP | No | No-Detects other CoV as well as SARS-CoV | Woo et al., 20056 |
6 to 8 GE | 16 | No | Houng et al., 200419 |
NP | No | RT-PCR more sensitive than culture | Chan et al., 200432 |
NP | 66 | Artus, compared Roche and in-house assays | Drosten et al., 200417 |
90 GE | No | pollb and nuc RT-PCR had similar sensitivities | Bressler and Nolte, 200416 |
10 GE | 86 | No 18S-rRNA as internal control | Poon et al., 200420 |
NP | 120 | One CHB PCR followed by second TaqMan PCR assay | Lau et al., 200314 |
0.01 pfu | 59 | LAMP detected seven additional positives | Thai et al., 200422 |